Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation. Issue 1 (2nd January 2020) - Wong, Eric; Davis, Joanne; Koldej, Rachel; Szer, Jeff; Grigg, Andrew; Ritchie, David